Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

046. COVID-19: Special Populations: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Special Populations

(497) Safety and tolerability of 2000mg intravenous sotrovimab dose in immunocompromised participants uninfected with SARS-CoV-2 in the PROTECT-V trial

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET
Location: Virtual